Patient No | Age | CD4+ count at CMV DX | Initial CMV therapy | Duration of CMV therapy (months) | CD4+ count when CMV therapy stopped | HIV viral load when CMV therapy stopped | Follow up since CMV therapy stopped (months) | Duration of HAART before CMV therapy | CD4+ count at last visit |
1 | 35 | 27 | IV GCV | 36 | 326 | UND | 24 | 23 | 675 |
2 | 41 | 65 | IV GCV | 8 | 235 | UND | 30 | 7 | 483 |
3 | 43 | 12 | IV GCV | 32 | 212 | UND | 33 | 15 | 296 |
4 | 28 | 11 | IV GCV | 17 | 262 | UND | 22 | 18 | 821 |
5 | 39 | 25 | IV GCV | 36 | 318 | UND | 22 | 21 | 798 |
6 | 27 | 3 | IV GCV | 39 | 449 | UND | 24 | 20 | 806 |
7 | 56 | 62 | IV GCV | 29 | 274 | UND | 27 | 22 | 383 |
8 | 38 | 31 | IV GCV | 16 | 306 | UND | 29 | 16 | 402 |
9 | 33 | 7 | IV GCV | 41 | 295 | UND | 18 | 31 | 493 |
10 | 34 | 43 | IV GCV | 30 | 273 | UND | 27 | 22 | 286 |
11 | 34 | 46 | IV GCV | 30 | 273 | UND | 27 | 21 | 461 |
12 | 47 | 54 | IV GCV | 19 | 238 | UND | 26 | 19 | 819 |
13 | 45 | 102 | IV GCV | 7 | 296 | UND | 21 | 6 | 360 |
14 | 37 | 76 | IV GCV | 8 | 231 | UND | 31 | 7 | 292 |
15 | 37 | 12 | IV GCV | 31 | 274 | UND | 20 | 29 | 323 |
16 | 37 | 95 | IV GCV | 8 | 297 | UND | 31 | 7 | 450 |
17 | 41 | 6 | IV GCV | 24 | 216 | UND | 22 | 22 | 427 |
18 | 39 | 18 | IV GCV | 25 | 287 | UND | 23 | 25 | 545 |
19 | 36 | 6 | IV GCV | 23 | 347 | UND | 30 | 19 | 738 |
20 | 29 | 86 | IV GCV | 11 | 295 | UND | 19 | 15 | 463 |
21 | 28 | 96 | IV GCV | 17 | 286 | UND | 19 | 21 | 374 |
22 | 34 | 35 | IV GCV | 13 | 219 | UND | 21 | 5 | 296 |
23 | 29 | 25 | IV GCV | 18 | 379 | UND | 21 | 11 | 542 |
24 | 30 | 55 | IV GCV | 7 | 275 | UND | 21 | 8 | 293 |
25 | 22 | n/a | IV GCV | 38 | 304 | 230 | 14 | 13 | 581 |
26 | 38 | 27 | IV GCV | 41 | 489 | 321 | 14 | 28 | 872 |
27 | 37 | 8 | IV GCV | 21 | 184 | UND | 37 | 7 | 422 |
28 | 39 | 26 | IV GCV | 43 | 176 | UND | 24 | 20 | 506 |
29 | 27 | 87 | IV GCV | 16 | 163 | UND | 21 | 17 | 285 |
30 | 31 | 36 | IV GCV | 22 | 169 | UND | 22 | 13 | 618 |
31 | 36 | 32 | IV GCV | 15 | 158 | UND | 18 | 6 | 373 |
32 | 34 | 45 | IV GCV | 11 | 156 | UND | 21 | 8 | 747 |
33 | 31 | 27 | IV GCV | 9 | 149 | UND | 18 | 7 | 216 |
34 | 39 | 62 | IV GCV | 25 | 152 | UND | 17 | 11 | 181 |
35 | 41 | 74 | IV GCV | 9 | 185 | UND | 5 | 9 | 335 |
36 | 33 | 46 | IV GCV | 11 | 171 | UND | 7 | 10 | 562 |
37 | 38 | 65 | IV GCV | 9 | 146 | UND | 6 | 9 | 268 |
38 | 35 | 73 | IV GCV | 10 | 162 | UND | 6 | 10 | 194 |
39 | 32 | 41 | IV GCV | 10 | 181 | UND | 7 | 9 | 308 |
40 | 37 | 71 | IV GCV | 9 | 168 | UND | 7 | 13 | 452 |
41 | 28 | 67 | IV GCV | 13 | 143 | UND | 6 | 8 | 312 |
Mean | 35.5 | 44.6 | 20.4 | 246.8 | 275.5 | 20.4 | 14.8 | 464.8 | |
Maximun | 56 | 102 | 43 | 489 | 321 | 37 | 31 | 872 | |
Minimun | 22 | 3 | 7 | 143 | 230 | 5 | 5 | 181 | |
Median | 36 | 42 | 17 | 238 | 275.5 | 21 | 13 | 427 |
CMV = cytomegalovirus retinitis; IV GCV = intravenous ganciclovir; HAART = highly active antiretroviral therapy; UND = undetectable.